Close Menu

MIT

Its first client, Haystack Bio, will use Genecloud to analyze and store single-cell genomics data for a proprietary platform it is developing for the immunotherapy market.

Researchers led by MIT's Jim Collins have built upon their paper-based Ebola test and are hoping to find a partner to help scale production and manufacturing of the test.

Tech-Transfer Maven

Lita Nelsen from the Massachusetts Institute of Technology's technology-transfer office is retiring after decades there.

Fight, Fight, Fight!

The USPTO has become involved in the CRISPR-Cas9 patent dispute.

The patent office has named the Broad Institute, et al. as the junior party in the proceedings and the University of California, et al. as the senior party.

By coupling a microfluidic platform and RNA sequencing, researchers found that single cells belonging to the same lineage have similar transcriptomic profiles.

Feng Zhang has shown how to systematically find and improve CRISPR systems, but scientists haven't settled on how to evaluate them for clinical use.

Scientists from the Zhang laboratory have systematically interrogated the protein structure of Cas9 to optimize its genome editing specificity.

A study in Molecular Cell shows CRISPR-Cas9-like genome editing in human cells and suggests one protein could be an RNA-guided, RNA-cleaving endonuclease.

A method developed at MIT creates polyacrylamide beads around droplets containing single cells to sequester bacterial genomes and allow for harsh lysis conditions; it then uses concatenated PCR and sequencing to address links between phylogeny and function.

Pages

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.